Fisher & Paykel Healthcare Corporation Limited (ASX: FPH) - Share Price
Current share price for FPH : $32.740 0.76 (2.38%)+
Fisher & Paykel Healthcare is a designer, manufacturer and marketer of products and systems for use in respiratory care, surgery and the treatment of obstructive sleep apnea. The company products are sold in over 120 countries.
FPH General Information +
| ASX Code | FPH |
| Website | http://www.fphcare.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 19,228 |
| FPH Share Price | $32.740 |
| Day High | $32.850 |
| Day Low | $32.100 |
| Last Close | $31.980 |
| FPH Share Price Movement | $0.76 ( 2.38% ) |
Prices as at 16:40, 3 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Fisher & Paykel Healthcare Corporation Limited (FPH) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 27.01¢ | 0% | 22 Jun 2026 | 3 Jul 2026 | - | - | - |
| Result | 16.52¢ | 0% | 3 Dec 2025 | 16 Dec 2025 | - | - | - |
| HFResult | 22.26¢ | 0% | 23 Jun 2025 | 4 Jul 2025 | - | - | - |
See all dividends from Fisher & Paykel Healthcare Corporation Limited (FPH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Fisher & Paykel Healthcare Corporation Limited (FPH) price-sensitive announcements
FPH - Preliminary Final Report
Fisher & Paykel Healthcare Corporation Limited reported strong financial performance for t
Fisher & Paykel Healthcare Corporation Limited (FPH)
26 May 2026 | 7:30 AM
26 May 2026 | 7:30 AM
FPH - Profit Guidance
Fisher & Paykel Healthcare Corporation Limited updated its financial year 2026 revenue and
Fisher & Paykel Healthcare Corporation Limited (FPH)
23 Feb 2026 | 7:30 AM
23 Feb 2026 | 7:30 AM
FPH - Half Yearly Report and Accounts
Fisher & Paykel Healthcare Corporation Limited reported a strong financial performance in
Fisher & Paykel Healthcare Corporation Limited (FPH)
26 Nov 2025 | 7:30 AM
26 Nov 2025 | 7:30 AM
FPH - FPH provides first half guidance for FY26
Fisher & Paykel Healthcare Corporation Limited provided guidance for the first half of the
Fisher & Paykel Healthcare Corporation Limited (FPH)
21 Aug 2025 | 7:30 AM
21 Aug 2025 | 7:30 AM
Fisher & Paykel Healthcare Corporation Limited (FPH) Recent ASX Announcements
FPH Financial Summary
| Year to Mar | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $369.56 | $62.68 | 20.50% | 50.40 | 46.74 | 1.48% | 0.0% |
| 2025F | $306.71 | $52.02 | 24.40% | 60.73 | 39.37 | 1.25% | 0.0% |
| 2024A | $245.09 | $41.82 | -0.30% | 52.86 | 38.47 | 1.74% | 0.0% |
FPH Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| Cochlear Limited (COH) | $7,871M | 0.0171 | -0.1883 | 0.0862 | 20.1110 | 24.7761 | 22.8108 | 3.57% | 2.88% | 3.07% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $18,782M | 0.1388 | 0.1340 | 0.1883 | 48.3593 | 42.6457 | 35.8882 | 1.36% | 1.45% | 1.64% |
| ResMed Inc. (RMD) | $16,747M | 0.3087 | 9.7641 | 0.0805 | 201.6506 | 18.7336 | 17.3378 | 1.14% | 1.20% | 1.26% |
FPH Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 1.39 | 47.80 | 10.90 | 2.98 |
| Market | 0.57 | 17.20 | 1.59 | 0.98 |
| Sector | 0.70 | 20.50 | 1.62 | 2.64 |
FPH Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Lewis George Gradon | Chief Executive Officer, Managing Director | 1 Apr 2016 |
| Sir Michael Grenfell Daniell | Non-Executive Director | 16 Nov 2001 |
| Dr Lisa Margaret McIntyre | Non-Executive Director | 1 Oct 2021 |
| Mr Andrew Mark Cross | Non-Executive Director | 1 Oct 2024 |
| Mr Graham McLean | Non-Executive Director | 1 Oct 2023 |
| Dr Cather Simpson | Non-Executive Director | 1 Jun 2022 |
| Ms Anna Curzon | Non-Executive Director | 1 Feb 2026 |
| Mr Neville Mitchell | Non-Executive Director, Non-Executive Chairman | 12 Nov 2018 |
Fisher & Paykel Healthcare Corporation Limited (FPH) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 17 Feb 2025 | MCLEAN, Graham | Buy | Indirect Shares | 1,000 | $32.300 | $32,300.000 |
| 12 Sep 2024 | MCLEAN, Graham | Buy | Indirect Shares | 800 | $34.915 | $27,932.000 |
| 21 Sep 2022 | O'DWYER, Donal | Buy | Indirect Shares | 3,000 | $19.261 | $57,782.000 |
See all changes in directors' interest & trades for Fisher & Paykel Healthcare Corporation Limited (FPH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
FPH Management
| Name | Position |
|---|---|
| Lyndal York | Chief Financial Officer |
| Andy Niccol | Chief Operating Officer |
| Raelene Leonard | Company Secretary |
| Desh Edirisuriya | General Manager - New Zealand Operations |
| Marcus Driller | Vice President - Corporate |
| Nicola Talbot | Vice President - Human Resources |
| Nicholas Fourie | Vice President - Information & Communication Technology |
| Jonti Rhodes | Vice President - Network Design, Facilities, Infrastructure & Sustainability |
| Andrew Somervell | Vice President - Products & Technology |
| Brian Schultz | Vice President - Quality, Safety & Regulatory Affairs |
| Justin Callahan | Vice President - Sales & Marketing |
| Winston Fong | Vice President - Surgical Technologies |
FPH Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Fisher & Paykel Healthcare Corporation Limited (FPH). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 44,727,643 (7.62%) | BlackRock, Inc. and related bodies corporate |
| 41,537,167 (7.07%) | Australiansuper Pty Ltd |
FPH Calendar of Events
| Date | Event |
|---|---|
| 25 May 2027 | Report (Prelim) |
| 25 November 2026 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
